Your browser doesn't support javascript.
loading
[Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)]. / Aktuelle Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands zur therapeutischen intravitrealen Anwendung von Ocriplasmin (JETREA®) in der Augenheilkunde (Stand Mai 2013).
Klin Monbl Augenheilkd ; 230(6): 629-34, 2013 Jun.
Article in De | MEDLINE | ID: mdl-23794431

Full text: 1 Database: MEDLINE Main subject: Ophthalmology / Peptide Fragments / Fibrinolysin / Eye Diseases / Intravitreal Injections Type of study: Guideline / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: De Year: 2013 Type: Article

Full text: 1 Database: MEDLINE Main subject: Ophthalmology / Peptide Fragments / Fibrinolysin / Eye Diseases / Intravitreal Injections Type of study: Guideline / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: De Year: 2013 Type: Article